566 related articles for article (PubMed ID: 17454012)
41. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
[TBL] [Abstract][Full Text] [Related]
42. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.
King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK
J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792
[TBL] [Abstract][Full Text] [Related]
43. AUDIT-C as a brief screen for alcohol misuse in primary care.
Bradley KA; DeBenedetti AF; Volk RJ; Williams EC; Frank D; Kivlahan DR
Alcohol Clin Exp Res; 2007 Jul; 31(7):1208-17. PubMed ID: 17451397
[TBL] [Abstract][Full Text] [Related]
44. Buprenorphine injection in Melbourne, Australia--an update.
Aitken CK; Higgs PG; Hellard ME
Drug Alcohol Rev; 2008 Mar; 27(2):197-9. PubMed ID: 18264882
[TBL] [Abstract][Full Text] [Related]
45. Obstacles to successful HCV treatment in substance addicted patients.
Cooper CL
J Addict Dis; 2008; 27(2):61-8. PubMed ID: 18681192
[TBL] [Abstract][Full Text] [Related]
46. Gender differences in the relationships between alcohol, tobacco and mental health in patients attending an emergency department.
Alati R; Kinner S; Najman JM; Fowler G; Watt K; Green D
Alcohol Alcohol; 2004; 39(5):463-9. PubMed ID: 15289208
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
Winstock AR; Lea T; Sheridan J
Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
[TBL] [Abstract][Full Text] [Related]
48. Assessment of alcohol consumption among hepatitis C-positive people receiving opioid maintenance treatment using direct ethanol metabolites and self-report: a pilot study.
Wurst FM; Haber PS; Wiesbeck G; Watson B; Wallace C; Whitfield JB; Halter C; Weinmann W; Conigrave KM
Addict Biol; 2008 Sep; 13(3-4):416-22. PubMed ID: 17711559
[TBL] [Abstract][Full Text] [Related]
49. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
Spire B; Lucas GM; Carrieri MP
Int J Drug Policy; 2007 Aug; 18(4):262-70. PubMed ID: 17689374
[TBL] [Abstract][Full Text] [Related]
50. Treatment for hepatitis C virus infection among current injection drug users in Australia.
Matthews G; Kronborg IJ; Dore GJ
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S325-9. PubMed ID: 15768342
[TBL] [Abstract][Full Text] [Related]
51. Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review.
Bell J; Mutch C
Drug Alcohol Rev; 2006 Mar; 25(2):167-71. PubMed ID: 16627307
[TBL] [Abstract][Full Text] [Related]
52. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.
Treloar C; Newland J; Rance J; Hopwood M
J Viral Hepat; 2010 Dec; 17(12):839-44. PubMed ID: 20070504
[TBL] [Abstract][Full Text] [Related]
53. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.
Doab A; Treloar C; Dore GJ
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S313-20. PubMed ID: 15768340
[TBL] [Abstract][Full Text] [Related]
54. Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy.
Kay-Lambkin FJ; Baker AL; Lewin TJ; Carr VJ
Addiction; 2009 Mar; 104(3):378-88. PubMed ID: 19207345
[TBL] [Abstract][Full Text] [Related]
55. Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for hepatitis C virus infection.
Canfield KM; Smyth E; Batki SL
Subst Use Misuse; 2010 Mar; 45(4):496-514. PubMed ID: 20141461
[TBL] [Abstract][Full Text] [Related]
56. Screening and brief intervention for risky alcohol consumption in the workplace: results of a 1-year randomized controlled study.
Hermansson U; Helander A; Brandt L; Huss A; Rönnberg S
Alcohol Alcohol; 2010; 45(3):252-7. PubMed ID: 20406791
[TBL] [Abstract][Full Text] [Related]
57. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
Nielsen S; Dietze P; Lee N; Dunlop A; Taylor D
Addiction; 2007 Apr; 102(4):616-22. PubMed ID: 17286641
[TBL] [Abstract][Full Text] [Related]
58. Knowledge about Hepatitis-C among methadone maintenance treatment patients in Israel.
Cohen-Moreno R; Schiff M; Levitt S; Bar-Hamburger R; Strauss S; Neumark Y
Subst Use Misuse; 2010; 45(1-2):58-76. PubMed ID: 20025439
[TBL] [Abstract][Full Text] [Related]
59. Medical/psychiatric comanagement by nurse practitioners in chronic hepatitis C treatment: a case study.
Gardenier D; Neushotz LA; O'Connor-Moore N
Arch Psychiatr Nurs; 2007 Apr; 21(2):87-90. PubMed ID: 17397690
[TBL] [Abstract][Full Text] [Related]
60. Substance misuse, anxiety and depression and urgency of presentation to a public emergency department in Australia.
Kinner SA; Alati R; Watt K; Najman JM; Fowler G; Green D
Emerg Med Australas; 2005 Aug; 17(4):363-70. PubMed ID: 16091099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
